Skip to main content

Table 2 Study layout of patient material

From: The mitochondrial transporter SLC25A43 is frequently deleted and may influence cell proliferation in HER2-positive breast tumors

Patient cohorts

Number of patients

HER2-positive BC

85

ā€ƒSNP array

25

ā€ƒLOH

85

ā€ƒMutation analysis

29

ā€ƒIHC

71

HER2-negative BCa

52

Cervical cancera

65

Lung cancer (ā™€)a

18

  1. a, patients used for LOH analysis; BC, breast cancer; SNP, single nucleotide polymorphism; LOH, loss of heterozygosity; IHC, immunohistochemistry.